G-FINDER report 2016

The report analyses trends and patterns in 2015 for 35 neglected diseases - including TB - across 142 product areas including drugs, vaccines, diagnostics, microbicides and vector control products.

Read More →

Advocates call on PEPFAR to roll out LAM test

TB advocates urge PEPFAR to provide immediate access to the LAM test for TB diagnosis in HIV-positive people with advanced immunosuppression.

Read More →

Advocates call on Sequella to provide open access to sutezolid data

TB advocates appeal to Sequella to act in the interest of public health and provide open access to all existing sutezolid data.

Read More →

An Activist’s Guide to Tuberculosis Diagnostic Tools

The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.

Read More →

Advocates maintain pressure on the Ministry of Health to facilitate access to delamanid in Peru

TB advocates reiterate the important role the Ministry of Health must play in facilitating access to delamanid for Peruvians with multidrug-resistant TB.

Read More →

Health groups call on Indian Government to urgently make life-saving TB drug available

Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.

Read More →

Public health groups welcome Johns Hopkins University and Medicines Patent Pool agreement for development of promising new TB drug

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability.

Read More →

Advocates encourage Danaher to continue investments in Cepheid’s TB products

TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.

Read More →

Advocates call on the Indian Prime Minister to ensure availability of new TB drugs to combat drug-resistant TB

Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.

Read More →

Advocates encourage prioritization of drug-resistant TB research

TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.

Read More →

Page 1 of 77 · Total posts: 10

1 2 Last→